Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context
Detection Principle
ImmunoAssay-Antigen
Target
nucleoprotein
Testing Method Category
Testing Method - Additional Info
Analytical and clinical performance of a non-fluorescent ICT
Reported Performance
Sensitivity 74.2%, specificity: 100%
Sample Size
60 samples
Peer-reviewed
no
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements